“Partnering with RSI, which offers the ultimate end to end patient acquisition software, enables healthcare practices to leverage customized, data-driven strategies designed to enhance reporting, analytics, operational efficiency, and patient lifetime value. Their seamless integration with practice management, telecommunication, and marketing systems optimizes patient acquisition from inception of inquiry through to provider performance and patient satisfaction. This complements our mission of driving healthcare forward for all of our mCare managed services clients and new business,” said Daniel Livschutz, Senior Vice President of Business Development, Medicus IT.

Ryan Lehrl, Vice President at RSI, added, “RSI was founded on the principle that healthcare organizations should be able to grow their organizations profitably by understanding their return on investment across the entire patient acquisition spectrum. As HCIT continues to expand to meet the needs of our clients many will need to go through a transformation of their technology stack and we believe Medicus is a great partner to support that mission. When working together with Medicus, our mutual clients understand they have a partner for both the current state and future state of Healthcare IT. As the evolution of healthcare continues it is imperative that you’re not left behind and Medicus has proven its ability to shepherd healthcare through that journey.”

This partnership underscores Medicus’ unwavering commitment to fostering alliances that drive innovation and growth in the healthcare industry. As we continue to expand our capabilities, we remain dedicated to enabling healthcare providers to focus on their patients by ensuring their IT infrastructure and applications are secure, efficient, automated and scalable.

The post Medicus IT Announces Strategic Partnership with Red Spot Interactive first appeared on AI-Tech Park.

Inc. revealed today that Lightbeam Health Solutions, the leader in population health enablement technology and solutions, ranks on the 2024 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses. Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, Patagonia, and many other household-name brands gained their first national exposure as honorees on the Inc. 5000.

“Being recognized on the Inc. 5000 for the 6th time is a tremendous honor and a testament to the unwavering commitment of the entire Lightbeam team,” says Pat Cline, Chief Executive Officer of Lightbeam Health Solutions. “This achievement highlights our relentless pursuit of excellence and innovation as we continue to expand our capabilities and deliver transformative solutions in value-based care. We are incredibly proud of the progress we’ve made and deeply grateful for the support of our clients and partners. This recognition fuels our drive to achieve even greater success in the future.”

The Inc. 5000 class of 2024 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges. Among this year’s top 500 companies, the average median three-year revenue growth rate is 1,637 percent. In all, this year’s Inc. 5000 companies have added 874,458 jobs to the economy over the past three years.

For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, go to http://www.inc.com/inc5000. Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth from 2020 to 2023. To qualify, companies must have been founded and generating revenue by March 31, 2020. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2023.

“One of the greatest joys of my job is going through the Inc. 5000 list,” says Mike Hofman, who recently joined Inc. as editor-in-chief. “To see all the intrigue and surprising ways that companies are transforming sectors, from health care and AI to apparel and pet food, is fascinating for me as a journalist and storyteller. Congratulations to this year’s honorees, as well, for growing their businesses fast despite the economic disruption we all faced over the past three years, from supply chain woes to inflation to changes in the workforce.”

Lightbeam was recently recognized as 2024 Best in KLAS® for its Deviceless Remote Patient Monitoring® solution. The Lightbeam platform incorporates advanced capabilities like prescriptive AI to accelerate value-based care performance. By enabling payers and providers to align clinical and financial outcomes, Lightbeam eliminates administrative burdens and lowers total cost of care while improving health equity. Additionally, Lightbeam was further acknowledged as a 2024 Finalist for Microsoft’s Healthcare and Life Sciences Partner of the Year. To explore how Lightbeam’s prescriptive AI reduces cost like avoidable readmissions, download the case study here.

“Being recognized on the Inc. 5000 for the 6th time is a tremendous honor and a testament to the unwavering commitment of the entire Lightbeam team,” says Pat Cline, Chief Executive Officer of Lightbeam Health Solutions. “This achievement highlights our relentless pursuit of excellence and innovation as we continue to expand our capabilities and deliver transformative solutions in value-based care. We are incredibly proud of the progress we’ve made and deeply grateful for the support of our clients and partners. This recognition fuels our drive to achieve even greater success in the future.”

The Inc. 5000 class of 2024 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges. Among this year’s top 500 companies, the average median three-year revenue growth rate is 1,637 percent. In all, this year’s Inc. 5000 companies have added 874,458 jobs to the economy over the past three years.

For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, go to http://www.inc.com/inc5000. Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth from 2020 to 2023. To qualify, companies must have been founded and generating revenue by March 31, 2020. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2023.

“One of the greatest joys of my job is going through the Inc. 5000 list,” says Mike Hofman, who recently joined Inc. as editor-in-chief. “To see all the intrigue and surprising ways that companies are transforming sectors, from health care and AI to apparel and pet food, is fascinating for me as a journalist and storyteller. Congratulations to this year’s honorees, as well, for growing their businesses fast despite the economic disruption we all faced over the past three years, from supply chain woes to inflation to changes in the workforce.”

Lightbeam was recently recognized as 2024 Best in KLAS® for its Deviceless Remote Patient Monitoring® solution. The Lightbeam platform incorporates advanced capabilities like prescriptive AI to accelerate value-based care performance. By enabling payers and providers to align clinical and financial outcomes, Lightbeam eliminates administrative burdens and lowers total cost of care while improving health equity. Additionally, Lightbeam was further acknowledged as a 2024 Finalist for Microsoft’s Healthcare and Life Sciences Partner of the Year. To explore how Lightbeam’s prescriptive AI reduces cost like avoidable readmissions, download the case study here.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post Lightbeam Health Celebrates 6th Year on the 2024 Inc. 5000 first appeared on AI-Tech Park.

Wound Care Clinicians who use Intellicure’s SMART apps or its complete EHR solution can upload standard and fluorescence images and measurements captured with the MolecuLight device at the point-of-care to the patient’s record. The integrated platforms allow clinicians to optimize their workflow and document their patients’ wounds digitally.

The benefits of the MolecuLightDX and Intellicure integration include:

• Direct (Wi-fi enabled) EHR-to-device transfer of patient data
• Automatic upload of images from device-to-EHR
  • Digital wound measurement and standard wound images
  • Bacterial autofluorescence images denoting the presence and location of harmful bacteria and biofilm in and around wounds
• Scalable integration supporting the use of several DX devices per site

“Optimizing our customers’ clinical workflow is a top priority here at MolecuLight. We are proud to announce the inclusion of our MolecuLight platform in Intellicure EHR,” says Anil Amlani, CEO of MolecuLight Inc. “The MolecuLightDX is an extensively validated FDA-cleared Class II device that integrates three essential functions: detection of harmful bacteria linked to infection, digital wound measurement, and aid to clinicians in treatment planning. An extensive body of peer-reviewed publications demonstrates faster healing rates, better resource allocation, cost savings, and improved patient engagement all with the use of our advanced imaging platform.”

“Intellicure’s seamless wound care charting platform is a perfect match with Moleculight,” said Intellicure Chief Medical Officer Dr. Caroline Fife. “Intellicure is the only wound care EHR that provides relevant point-of-care clinical practice suggestions. The seamless integration of actionable information about potentially harmful bacteria is another step forward in optimizing patient care, and thus, wound outcome.” 

The MolecuLight i:X and DX are the only Class ll FDA-cleared, CE-Marked, and Health Canada approved imaging devices available in the market for the real-time detection of elevated bacterial burden in and around wounds. With a robust body of clinical evidence, the devices are used globally by leading wound care facilities.

Intellicure is a wound care software used by America’s advanced wound centers. Wound clinicians using Intellicure’s SMART apps for Cerner and Epic, wound care mobile apps, and/or Intellicure’s complete EHR solution enjoy clean clinical workflow, proven regulatory compliance, unparalleled reimbursement rates, and are recognized by CMS as leaders in quality patient care. Visit Intellicure.com for more information.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post MolecuLight Integrates with Intellicure EHR for Data and Image Transfer first appeared on AI-Tech Park.

“This acquisition brings together two industry leaders committed to enhancing access to diagnostic innovation for patients in North America,” said Jim Davis, Chairman, CEO, and President of Quest Diagnostics. “The combination of LifeLabs’ strong business and deep community presence with Quest’s specialized lab services and expertise creates a powerful opportunity to generate growth while improving care and outcomes for Canada’s expanding and aging population.”

Quest provides a comprehensive offering of tests requiring specialized skills, science, and technology in clinical areas such as cardiometabolic health, infectious diseases, Alzheimer’s disease, oncology and genomics.

“Joining forces with Quest Diagnostics marks a pivotal moment for LifeLabs. Quest’s extensive diagnostic capabilities and forward-thinking strategy will help the LifeLabs team enhance access to services and ultimately improve healthcare for Canadians,” said Charles Brown, President and CEO of LifeLabs. 

LifeLabs and its more than 6,500 employees will continue to operate under the LifeLabs brand and with the same management team and headquarters. Quest will provide LifeLabs with new expertise, innovations and resources to strengthen the services provided by LifeLabs. In addition to fostering greater access to specialized tests, the two companies will work together to improve online appointment scheduling and speed patient service centre processing. Quest will also support LifeLabs’ data security enhancements while ensuring Canadian patients’ health data remains in Canada.

“OMERS is proud to have supported and fostered LifeLabs’ growth into the prominent Canadian healthcare institution it is today,” said Michael Hill, Executive Vice President and Global Head of OMERS Infrastructure. “This transaction represents a significant achievement for OMERS and its members. We extend our best wishes to Quest and LifeLabs as they embark on their shared journey towards future success and innovation supporting patient care.”

Transaction Details
Quest has acquired 100% of the equity of LifeLabs. The transaction meets all of Quest’s criteria on growth, profitability and returns. Quest expects the transaction to generate approximately CAN $970 million (approximately USD $710 million) in annual revenues. The company expects the transaction to be slightly dilutive to GAAP earnings per share (EPS), due primarily to amortization of intangibles and other items, but $0.10-$0.15 accretive to adjusted EPS, in the first 12 months after closing. The company will provide updated financial guidance for the full year 2024 on its third quarter 2024 earnings call in October 2024. Additional terms were not disclosed.

Advisors
McCarthy Tétrault LLP served as legal advisor to Quest Diagnostics. Blake, Cassels & Graydon LLP served as legal advisor to OMERS. Evercore and CIBC Capital Markets served as financial advisors to OMERS.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post Quest Diagnostics Completes Acquisition of LifeLabs first appeared on AI-Tech Park.

eClinicalWorks®, the largest ambulatory cloud EHR, announced that Middletown Medical, a New York-based multi-specialty practice, witnessed significant improvements by implementing eClinicalWorks Cloud EHR and Revenue Cycle Management (RCM). By leveraging the system capabilities to the fullest, the practice reduced claim rejections, decreased claims submission lag, and secured substantial savings on return on investment (ROI).

Most notably since integration, handling workers’ compensation client claims has been revolutionized. From manually submitting these claims by paper, the practice now implements an electronic submission process, significantly improving cost savings.

“The integration of eClinicalWorks RCM solutions was the catalyst for our positive operational changes,” said Darcy Shepard, chief executive officer of Middletown Medical. “At Middletown Medical, we consistently strive to improve the quality and efficiency of our services. This innovative technology dramatically reduced our claim rejections, streamlined our claim submission process, and decreased claim submission lag. Furthermore, we eliminated the need for manual adjustments to a significant number of claims monthly. The digitization of our workers’ compensation client claims has not only led to significant cost savings but also contributed to environmental sustainability. Our partnership with eClinicalWorks is an investment in our continued pursuit of healthcare excellence.”

Girish Navani, chief executive officer and co-founder of eClinicalWorks said, “Through our innovative eClinicalWorks RCM solutions, fully supported by a smart, cloud-based EHR, Middletown Medical can elevate their existing operations and care models for future growth. We are proud to deliver an industry-leading RCM solution with superior quality, exceptional customer service, and a remarkable first-pass acceptance rate of 98% or more.”

Middletown Medical is a multi-specialty practice with over 145 providers across 22 locations in New York and surrounding areas. They provide high-quality primary, urgent, and specialty care, offering a full range of services that cater to the unique health requirements of their patient population. By combining the latest technological advancements and medical research, Middletown Medical seeks to improve its services while delivering exceptional patient care.

eClinicalWorks offers innovative, unified solutions that enhance interoperability, practice management, and patient engagement. eClinicalWorks solutions help healthcare providers optimize resources, focus on patient care, improve healthcare outcomes, and reduce costs.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post Middletown Medical Leverages eClinicalWorks RCM Solutions first appeared on AI-Tech Park.

Through the offering, an organization can gain access to a range of core language services, including video remote interpreting, over-the-phone interpreting, in-person interpreting, and translation. In addition, SPS will offer wraparound services and solutions tailored to the specific needs of each organization, determined through a thorough analysis and evaluation of their language access program.

“Operating a language service department has traditionally been seen as a cost associated with doing business. With SPS, we are changing this narrative and redefining language services as a strategic part of patient care that instead has the ability to reduce cost by addressing common issues like longer lengths of stay, missed appointments and higher readmissions driven by a lack of language service resources,” said Jacobia Solomon, President, AMN Language Services. “The launch of SPS represents a significant milestone for the healthcare industry, and we are proud to be at the forefront of this innovative approach to language access in healthcare.”

SPS addresses common challenges faced by healthcare organizations, including limited resources, high staff turnover, compliance issues, and difficulty in serving limited English proficient populations. By leveraging AMN Healthcare’s industry and operational expertise, SPS aims to enhance the reliability, efficiency, and cost-effectiveness of language access programs while improving patient outcomes. Leaders at Yuma Regional Medical Center, an SPS pilot site, have begun experiencing the solution’s effects.

“Our staff have been very impressed with the speed at which our patients are getting connected with an interpreter and with the quality of the interpretation that is occurring,” said Tina Rube, Director of Patient Experience & Care Advocacy for Yuma Regional Medical Center. “We finally have the resources to fully provide for our many non-English speaking patients.”

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post AMN Healthcare Introduces Strategic Partnership Solutions first appeared on AI-Tech Park.

Rhapsody, a global leader in digital health enablement and interoperability, today announced the results of a 2024 Forrester Consulting Total Economic Impact (TEI) study. The study reveals a significant 193% return on investment (ROI) over three years for interviewed health technology teams using Rhapsody integration solutions, offering an efficient and compliant approach to healthcare data integration.

The TEI study displays how the healthcare specialized solutions from Rhapsody meet the complex needs of healthcare technology organizations, including managing intricate data standards like FHIR, HL7, and DICOM, while ensuring compliance with global data privacy regulations. Unlike broad cross-industry platforms, the Rhapsody healthcare-specific approach enables faster, more scalable growth with fewer resources.

Key findings from the study are conveyed through the lens of a composite healthcare technology organization with $25M in annual recurring revenue, representative of interviewed Rhapsody customers. In addition to a 193% ROI, the study found a net present value of $1.59 million over three years, with a payback period of less than six months, plus:

• $1M in avoided costs (per $25M ARR) over three years due to streamlined staffing and reduced need for new hires.
  
• 30 days faster time to market per customer onboarded, leading to quicker revenue realization.
  
• Threefold increase in throughput and a significant reduction in time to production from weeks to days, enhancing operational efficiency.

The study demonstrates how Rhapsody integration solutions drive significant value by improving engineer and analyst efficiency, accelerating development lifecycles, and reducing time to market. Chief Technology and Product Officers at health technology companies of all sizes can use the study’s findings to build a business case for the potential cost savings and revenue generation for their own organizations.

The Chief Information Officer of a health technology company specializing in AI surgical platforms told Forrester, “By leveraging Rhapsody, we save valuable resources and focus on our core competency. Trusting the experts in software integration allows us to optimize our investments and achieve unparalleled efficiency. Let us leave the data intake and acquisition to those who know it best, so we excel in what truly matters to us.”

Sagnik Bhattacharya, CEO of Rhapsody, stated, “Rhapsody’s value lies in our deep specialization in healthcare data integration. The customers interviewed by Forrester clearly articulate how Rhapsody technology enabled their success and drove measurable ROI. Rhapsody is the most comprehensive and tech forward data integration platform; and we expect that this independent study will give our customer champions a clear framework to quantify monetary value to their organization.”

To discover how to build a business case for how Rhapsody could deliver benefits and ROI to your own organization, based on the study’s results, download the full Forrester Total Economic Impact study. Contact Rhapsody for a personalized consultation.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post Rhapsody Data Integration Delivered Significant ROI: Study first appeared on AI-Tech Park.

Headway, the company building a new mental healthcare system that everyone can access, today announced its appointment of Susan Chiang as Chief Information Security Officer. An accomplished technology executive, Chiang brings extensive security and strategy experience from companies like Cloudflare, Uber, and Salesforce, and healthcare consulting experience from Deloitte. She will oversee a team across data privacy and security, engineering and IT to make Headway the most trusted platform for mental health care providers and their patients.

According to the U.S. Department of Health and Human Services, cybersecurity incidents in healthcare are on the rise. The department reported a 93% increase in large breaches reported from 2018 to 2022, underscoring the critical need for investing in security and privacy as a top priority. This comes on the heels of the company’s announced expansion to Medicare Advantage and Medicaid plans.

“I’m excited to welcome Susan to Headway’s leadership team as we continue our significant investment in data privacy and security,” said Andrew Adams, Founder & CEO of Headway. “As we grow our platform, and expand to Medicare Advantage and Medicaid, security isn’t just a priority, it’s the foundation for everything we build. Susan is the ideal leader to help us make Headway the most trusted company in the space for our providers and their patients.”

Most recently, Chiang was Acting Chief Security Officer at Cloudflare, a large internet backbone company known for security and data privacy, where she oversaw engineering, operations, and technical program management functions for Security across the organization. Prior to Cloudflare, she was part of the security leadership team at Uber. Earlier in her career, she spent several years at Deloitte, where she focused on technology and healthcare consulting.

“I’m thrilled to join the team and leverage my cybersecurity and healthcare experience to help make it an even more trusted place for its providers and patients,” said Chiang. “As not only a cybersecurity professional, but also a patient myself, I deeply understand the importance of protecting medical data. I look forward to building a world-class engineering team that upholds providers and patients’ trust in Headway as the safest and most secure place for their medical data.”

In addition to her professional achievements, Chiang is a recognized advocate for empowering women and underrepresented groups in the security industry. She was honored as a Women in IT Security Advocate by SC Media in 2023. Chiang holds a degree from the University of California, Berkeley, and is based in San Francisco.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post Headway Welcomes Susan Chiang as Chief Information Security Officer first appeared on AI-Tech Park.

Etiometry, the leader in clinical decision-support software for critical care, today announced three new enterprise hospital agreements, further expanding its presence in adult and pediatric ICUs. These deals bring Etiometry’s AI-based clinical intelligence platform to a major healthcare system in a large Midwestern city and renowned healthcare providers in Illinois and Utah – representing a significant addition to Etiometry’s ever-growing customer base and presence across the critical care market.

“We are thrilled to share with these prestigious institutions the transformative power of Etiometry to enhance critical care delivery,” said Shane Cooke, CEO of Etiometry. “Our platform was developed for the ICU in partnership with ICU physicians, so it is specifically designed to empower clinicians with insights to achieve better standardization of care across their ICUs as well as individualization of care at the bedside for the most complex clinical situations in the hospital.”

The Etiometry platform seamlessly aggregates all relevant patient data in near real time and uses proprietary AI to analyze the data in order to uncover the need for escalation and de-escalation of care decisions. Brought together on one screen, this comprehensive view enables ICU care teams the unique opportunity to use data-driven insights to proactively identify potential patient complications, improve overall quality and help support both standardized and individualized care.

Automated reports and stress-free access to data in the platform’s Quality Improvement App, which has supported more than 150 research and quality initiatives, have revolutionized the ability to evaluate adoption, compliance, and effectiveness of quality initiatives, serving as the foundation for a Learning Health System. The abundance of clinical outcomes data associated with Etiometry use, including up to 36% reduction in ICU length of stay (Salvin et al. ‘17 AHA) and 41% reduction in readmissions (Gaies et al, Circulation ’23), are compelling – especially when considering the cost savings associated with these metrics and additional hospital revenue opportunity in terms of the ability to treat more patients.

“More and more healthcare leaders are seeking tangible ways to meet and exceed quality initiatives to enhance care,” said Cooke. “The Etiometry Platform offers a clear path to support these efforts. We look forward to supporting more customers in their pursuit of new and exciting quality benchmarks in high-acuity units.”

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post Etiometry Signs Several New Enterprise IDN Agreements first appeared on AI-Tech Park.

Bill payments made via paper check continue to cause friction for healthcare providers, straining their cashflow and diverting their valuable time to manual, time-intensive payment reconciliation. Likewise, data from the Federal Reserve shows that while overall check volume is on the decline, billions still use paper checks for bill payments, representing an opportunity to optimize medical bill payments in the healthcare space.

With Health iPASS Bank Bill Pay solution, powered by Mastercard RPPS, Health iPASS’ tens of thousands of US healthcare providers can now offer their patients the option to pay their medical bill(s) digitally where they already manage and pay their other bills. This complements other electronic forms of payment, catering to a segment of payors preferring to streamline their bill payments through one entity. It also avoids the need to share sensitive account details with multiple parties and minimizes check fraud.

“We’re thrilled to partner with Mastercard to help our healthcare providers get paid quickly and electronically to avoid the hassle of paper checks,” said Curtis Bauer, CEO of Health iPASS. “A costly problem for our healthcare providers is the considerable volume of their patients’ payments via offline paper checks. Adding online bank bill pay as a payment option on Health iPASS healthcare providers’ invoices will help our healthcare providers convert these unwanted checks into faster, more secure digital payments.”

“Providing a streamlined payments experience, while offering patients optionality in how they pay, continue to be critical needs for healthcare providers,” said Joseph Zeltzer, SVP, Product Management, Mastercard, North America. “Mastercard RPPS enables healthcare providers to get paid digitally through bank bill pay, reducing physical checks and ultimately improving cashflow and efficiency. We’re delighted to partner with Health iPASS to take another step towards helping solve critical payments needs for the healthcare industry.”

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

The post Health iPASS Enhances Healthcare Payments with Mastercard Partnership first appeared on AI-Tech Park.